Return
Brain-shuttle biologics chart new paths across the blood–brain barrier
E
DOI:10.1038/d41573-026-00121-6.png)
Abstract
En 中文
Efforts intensify to ferry large-molecule medicines into the brain, following the first FDA approval of an engineered biologic that overcomes delivery hurdles. Efforts intensify to ferry large-molecule medicines into the brain, following the first FDA approval of an engineered biologic that overcomes delivery hurdles.
Journal
IF:
101.8
Papers:
5.1K
Citations:
5.3W
Organization
No organization information available
